New Study to Get More Minorities Involved in Genetic Testing
826 articles
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
The Butterfly Effect and Living Every Day to My Fullest
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
New Study Focuses On Supportive Oncology Care At Home
Dr. Ryan Nipp is exploring the value of supportive oncology care at home for pancreatic cancer patients in a pilot clinical trial.
Testing an Approved Drug for a Specific Mutation
Researchers are testing a drug combination for melanoma in pancreatic cancer patients with a BRAF genetic mutation.
Most Cancer Mutations Are Random DNA Mistakes
In a large study, Dr. Bert Vogelstein of Johns Hopkins found that a majority of cancers, including pancreatic cancer, are caused by random mutations of DNA.
Lucky to Find It Early
When Jeneen Genna did not feel well her doctor searched until they found pancreatic cancer. The BRCA2 mutation has her in a clinical trial.
Fighting On To See Her Children Grow Up
Despite aggressive pancreatic cancer, with a BRCA-like genetic mutation, Dr. Jill Pechacek is determined to stay alive to see her children grow up.
Planning Every Day to Live
Tammy Richardson has focused her pancreatic cancer treatment choices on maintaining her quality of life, so she can travel and see family.
Living with Pancreatic Cancer as a Long-Term Survivor
Roberta Luna has been fighting pancreatic cancer since 2002, but the disease has been part of her life for much longer. Read about her battle.
Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
Laboratory Study Shows Keto Diet May Enhance Chemotherapy
Dr. Joshua Rabinowitz’s initial study has found that a Keto diet may enhance the effects of chemotherapy and treatment for pancreatic cancer.
Can a Pancreatic Cancer Screening Test Become a Reality?
Dr. Felice Schnoll-Sussman discusses screening options for pancreatic cancer and criteria for people who might want to get screened.
My BRCA2 Mutation Turned Out to Be Both the Curse and the Cure
Sharon Seibel knew she had the BRCA2 mutation but was unaware of the link to pancreatic cancer. Her chemotherapy was one for BRCA carriers.